Two Units Of Umbilical Cord Blood Reduce Risk Of Leukemia Recurrence

Patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning. This finding has the potential to change the current medical practice of using one unit of UCB for treatment of patients who are at high risk for recurrence of leukemia and other cancers of the blood and bone marrow.

Read the whole article on Science Daily

More from Science Daily